Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo

Stroke. 2003 May;34(5):1281-6. doi: 10.1161/01.STR.0000065828.18661.FE. Epub 2003 Apr 3.

Abstract

Background and purpose: In light of recent evidence suggesting that an upregulation of K+ efflux mediated by outward delayed rectifier (I(K)) channels promotes central neuronal apoptosis, we sought to test the possibility that blockers of I(K) channels might be neuroprotective against hypoxia/ischemia-induced neuronal death.

Methods: Membrane currents were recorded with the use of patch clamp recordings in cultured murine cortical neurons. Protective effects of K+ channel blockers were examined in rats subjected to transient middle cerebral artery occlusion followed by 14-day reperfusion.

Results: The K+ channel blocker tetraethylammonium (TEA) (5 mmol/L) selectively blocked I(K) without affecting N-methyl-D-aspartate receptor-mediated current or voltage-gated Ca2+ currents. Both TEA and a lipophilic K+ channel blocker, clofilium, attenuated neuronal apoptosis induced by hypoxia in vitro and infarct volume induced by ischemia in vivo.

Conclusions: These data are consistent with the idea that K+ channel-mediated K+ efflux may contribute to ischemia-triggered apoptosis and suggest that preventing excessive K+ efflux through K+ channels may constitute a therapeutic approach for the treatment of stroke.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / pathology
  • Calcium / metabolism
  • Calcium Channels / metabolism
  • Calcium Signaling / drug effects
  • Carotid Artery, Common
  • Cell Hypoxia / drug effects
  • Cells, Cultured / drug effects
  • Cells, Cultured / pathology
  • Cerebral Cortex / cytology
  • Culture Media / pharmacology
  • Drug Evaluation, Preclinical
  • Glucose / pharmacology
  • Hypoxia, Brain / drug therapy*
  • Hypoxia, Brain / pathology
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / drug therapy
  • Infarction, Middle Cerebral Artery / pathology
  • Ion Transport / drug effects
  • Ligation
  • Male
  • Mice
  • Middle Cerebral Artery
  • Neurons / drug effects*
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Patch-Clamp Techniques
  • Potassium / metabolism
  • Potassium Channel Blockers / pharmacology
  • Potassium Channel Blockers / therapeutic use*
  • Quaternary Ammonium Compounds / pharmacology*
  • Rats
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / physiology
  • Tetraethylammonium / pharmacology*

Substances

  • Calcium Channels
  • Culture Media
  • Neuroprotective Agents
  • Potassium Channel Blockers
  • Quaternary Ammonium Compounds
  • Receptors, N-Methyl-D-Aspartate
  • Tetraethylammonium
  • clofilium
  • Glucose
  • Potassium
  • Calcium